Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

Mother of sick boy seeks legalization of medical marijuana

Jun 18, 2018

LONDON — The mother of an epileptic boy at the center of a debate over medical marijuana in the U.K. is calling for an urgent meeting with ministers to discuss liberalizing British policy. Charlotte Caldwell said Sunday she also wants assurances from the government that her 12-year-old son Billy will be able to keep receiving cannabis oil once a 20-day emergency supply approved by the government runs out. Caldwell wants to make sure there isn't "another battle" over the medicine that she believes has warded off potentially life-threatening seizures for her son. Billy remains hospitalized in London for severe seizures...

UK changes course, allows epileptic boy to use cannabis oil

Jun 18, 2018

LONDON — The British government changed course Saturday in a case concerning cannabis oil, saying an epileptic boy can be treated with it after his mother said he needed it to survive severe seizures. Home Secretary Sajid Javid said he has agreed to urgently issue a license to allow Billy Caldwell, a 12-year-old from Northern Ireland, to be treated with the oil. He said his decision was based on advice from senior doctors who say that Caldwell, who was hospitalized overnight in London, faces a medical emergency. Javid said the British government's immediate priority was to make sure Caldwell receives...

Beloved Glasgow School of Art badly damaged by a 2nd fire

Jun 18, 2018

LONDON — Glasgow has suffered a major blow as a second severe fire in four years has gutted the historic Glasgow School of Art, one of the Scottish city's most beloved cultural treasures. Fire officials said Saturday the fire was mostly under control and that there seemed to be no casualties, but said that every floor of the historic building at the heart of the city center was damaged. The cause of the fire has not been established. It came near the end of a multimillion pound (dollar) project to restore the building to its former glory after a 2014...

Famed Glasgow art school ravaged by fire again

Jun 18, 2018

LONDON — A large blaze ripped through an architecturally important building at the Glasgow School of Art, the second time in four years that fire has damaged the famed Scottish school. More than 60 firefighters were battling the blaze early Saturday morning, and images posted on social media showed flames and smoke billowing from the roof of the Glasgow School of Art's Mackintosh Building. Scottish First Minister Nicola Sturgeon said she was heartbroken by the fire, tweeting: "This is clearly an extremely serious situation. My first thoughts tonight are for the safety of people - but my heart also breaks...

Stephen Hawking's ashes buried in Westminster Abbey

Jun 18, 2018

LONDON — The ashes of Stephen Hawking were buried Friday in a corner of Westminster Abbey that honors some of Britain's greatest scientists, between the graves of Charles Darwin and Isaac Newton. More than 1,000 people attended a service of thanksgiving in the ancient abbey for the physicist, who died in March at age 76 after decades of living with motor neuron disease. When he was diagnosed, aged 22, he was given only a few years to live. Hawking conducted groundbreaking research into black holes and the origins of the universe, and gained global fame as a popularizer and communicator...

Sign up now!